RxDoctor Payments Data

Michelle Johnson, DO

Family Medicine · Canton, SDNPI 1912107426

Payments from drug & device makers

$492in general payments, 2019–2025

Across 31 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$102
  • Novo Nordisk$86
  • Amgen$68
  • Merck$63
  • Novartis$32
  • Lilly USA, LLC$28
  • plus $114 from 8 others

What the payments were for

  • Food & beverage$492100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$492 in reported general payments places this provider in the 65th percentile of 408 family medicine providers in South Dakota.

See all family medicine providers in South Dakota

Medicare billing

Part B allowed, 2024
$38,615
Medicare patients
110
Services billed
799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide104$112,415
EliquisApixaban228$97,120
XareltoRivaroxaban47$31,739
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$19,921
MyrbetriqMirabegron81$19,372
FarxigaDapagliflozin Propanediol25$16,765
AbrysvoRsv Vacc, Pref A And Pref B/Pf45$13,208
Repatha SureclickEvolocumab23$12,954
Potassium Chloride342$10,554
JanuviaSitagliptin Phosphate16$10,499
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$10,458
LinzessLinaclotide17$9,868
Tresiba Flextouch U-100Insulin Degludec15$9,398
Breo ElliptaFluticasone/Vilanterol15$7,304
InvokametCanagliflozin/Metformin Hcl12$6,755

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$86$112,415104 claims
PfizerEliquis, Abrysvo$14$110,327273 claims
Johnson & JohnsonXarelto, Invokamet$12$38,49459 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$11$30,18461 claims
Astellas Pharma US IncMyrbetriq$15$19,37281 claims
AbbVieLinzess, Savella$102$14,86938 claims
MerckJanuvia$63$10,49916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 408 family medicine providers in South Dakota.

Other family medicine in Canton

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →